New IVI Research Shows Challenges with ICER Budget Impact Forecasting

2020-03-19T15:44:21-06:00December 20th, 2018|Publications|

IVI research into six pre-2016 ICER studies reveals an overestimation of “unmanaged” drug use and drug cost trends. The peer-reviewed research, published in Value in Health, illustrates the difficulty in predicting budget impact and the consequences of not accounting for uncertainty in value assessment.

Read the full article here.